Cytomegalovirus-mediated myelosuppression
Lagneaux, L.; Delforge, A.; Stryckmans, P.; Bron, D.
Experimental Hematology 21(7): 837-838
1993
ISSN/ISBN: 0301-472X PMID: 8391469 Document Number: 410318
Document emailed within 1 workday
Related Documents
Sambucetti, L.C.; Cherrington, J.M.; Wilkinson, G.W.; Mocarski, E.S. 1989: NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation EMBO Journal 8(13): 4251-4258Shigeoka, Y. 2012: Myelosuppression Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 147-152
Abena, P.A.; Mathieux, V.G.; Scheiff, J.M.; Michaux, L.M.; Vandercam, B.C. 2001: Linezolid and reversible myelosuppression JAMA 286(16): 1973; Author Reply 1974
Shigeoka, Y.; Shimizu, E. 2007: Myelosuppression due to antineoplastic agents Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 287-293
Alberts, D.S. 1999: Protection by amifostine of cyclophosphamide-induced myelosuppression Seminars in Oncology 26(2 Suppl 7: 37-40
Adler, S.P.; Nigro, G. 2008: The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease Herpes: the Journal of the Ihmf 15(2): 24-27
Metselaar, H.J.; Velzing, J.; Rothbarth, P.H.; Simoons, M.L.; Bos, E.; Weimar, W. 1987: A pharmacokinetic study of anti-cytomegalovirus hyperimmunoglobulins in cytomegalovirus seronegative cardiac transplant recipients Transplantation Proceedings 19(5): 4063-4065
Charak, B.S. 1991: Amelioration of high dose cyclophosphamide-induced myelosuppression National Medical Journal of India 4(1): 30
Lautenschlager, I.; Ahonen, J.; Eklund, B.; Höckerstedt, K.; Isoniemi, H.; Salmela, K.; Häyry, P. 1990: Detection of cytomegalovirus-specific early antigens from blood leukocytes and bronchoalveolar lavage cells in the diagnosis of active cytomegalovirus infection in transplant patients Transplantation Proceedings 22(1): 233
Ogilvie, G.K.; Elmslie, R.E.; Cecchini, M.; Walters, L.M.; Pearson, F.C. 1992: Use of a biological extract of Serratia marcescens to decrease doxorubicin-induced myelosuppression in dogs American Journal of Veterinary Research 53(10): 1787-1790
Khoo, K.S.; Ang, P.T. 1995: Extract of astragalus membranaceus and ligustrum lucidum does not prevent cyclophosphamide-induced myelosuppression Singapore Medical Journal 36(4): 387-390
Shevchuk, O.O.; Posokhova, К.А.; Todor, I.N.; Lukianova, N.Yu.; Nikolaev, V.G.; Chekhun, V.F. 2015: Prevention of myelosuppression by combined treatment with enterosorbent and granulocyte colony-stimulating factor Experimental Oncology 37(2): 135-138
Suzuki, H.; Sasada, S.; Matsuda, Y.; Otani, Y.; Morishita, N.; Kobayashi, M.; Okamoto, N.; Hirashima, T.; Matsui, K.; Kawase, I. 2008: Two cases of severe myelosuppression from amrubicin in previously-treated small cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 35(3): 491-493
Dygaĭ, A.M.; Zhdanov, V.V.; Minakova, M.I.; Ryzhakov, V.M.; Gol'dberg, E.D. 1997: The role of proliferation and differentiation of the hematopoietic cell precursors during regeneration of hematopoiesis in cytostatic myelosuppression Biulleten' Eksperimental'noi Biologii i Meditsiny 124(12): 616-620
Mihăilescu, R.; Arama, V.; Paraschiv, S.; Streinu-Cercel, A.; Oţelea, D.; Munteanu, D.; Iosipenco, M.; Chiotan, C.; Benea, O.E.; Mărdărescu, M.; Rădulescu, M.; Hristea, A.; Ungurianu, R.; Aramă, S.S.; Cercel, A.S.; Călin, R.; Băicuş, C. 2008: Impact of highly active antiretroviral therapy on cytomegalovirus viraemia in the absence of specific anti-cytomegalovirus therapy Romanian Journal of Internal Medicine 46(4): 305-311
Kovacs, C.J.; Kerr, J.A.; Daly, B.M.; Evans, M.J.; Johnke, R.M. 1998: Interleukin 1 alpha (IL-1) and macrophage colony-stimulating factor (M-CSF) accelerate recovery from multiple drug-induced myelosuppression Anticancer Research 18(3a): 1805-1812
Gilbert, G.L.; Hayes, K.; Hudson, I.L.; James, J. 1989: Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group Lancet 1(8649): 1228-1231
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897
Levy, P.C.; Looney, R.J.; Shen, L.; Graziano, R.F.; Fanger, M.W.; Roberts, N.J.; Ryan, D.H.; Utell, M.J. 1990: Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysis Journal of Immunology 144(10): 3693-3700
Moqbel, R.; MacDonald, A.J.; Kay, A.B. 1985: Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro Clinical and Experimental Immunology 59(3): 577-586